ArkAb developed raw materials for the quality controls of immunoassays looking for Ig anti-SARS-COV-2 in patients samples. These products will be available for IVD manufacturers first quarter of 2021.
During the pandemic, ArkAb and B Cell Design had to protect their teams first so adapt working conditions: working organization, answer to containment measures...